Dear Members of the UCSF Community,
I am writing to share the news that Paul Jenny, senior vice chancellor for finance and administration, has been named Senior Vice President and Chief Financial Officer at Cincinnati Children’s Hospital Medical Center (CCHMC), effective January 25, 2021.
Since Paul joined UCSF in 2016, the University has undergone a period of rapid expansion, with significant growth in our clinical and research enterprises. During this period, UCSF also added more than one million square feet through capital projects such as the Joan and Sanford I. Weill Neurosciences Building, the Bakar Precision Cancer Medicine Building, and the Wayne and Gladys Valley Center for Vision, to name just a few.
As UCSF has grown in size and complexity, we have benefited from Paul’s leadership and wise stewardship of resources. In leading UCSF’s Finance and Administrative Services (FAS) organization, he has helped to advance our public mission by strengthening UCSF’s operational backbone. During his tenure, Paul has led numerous critical projects spanning the entire UCSF enterprise, including those undertaken by Audit and Advisory Services, Finance, Campus Life Services, Real Estate, Human Resources, Information Technology, UCSF Police Department, the Program Management Office, and the Anchor Institution Initiative.
I have valued Paul’s strategic counsel over the years and will miss working with him in his roles on both the Chancellor’s Executive Team and Chancellor’s Cabinet. I have no doubt that he will make equally important contributions at CCMHC, which is one of most distinguished pediatric hospitals in the country.
In the coming weeks, we will be taking steps...
Dear UCSF Community,
As we enter the final weeks of 2020, encouraging news on the COVID-19 vaccine front is helping to bring this difficult year to a close with a renewed sense of hope.
Yesterday, a vaccine advisory panel commissioned by the Food and Drug Administration (FDA) recommended that the FDA grant Emergency Use Authorization to Pfizer’s COVID-19 vaccine. The FDA’s approval is expected any day, and preparations are already under way at UCSF.
Approval of the Pfizer vaccine will mark an important turning point, but it will take months before this and other vaccines become widely available. Even as the vaccine distribution expands, we must recognize the serious threat the coronavirus continues to pose to public health—especially at a time when community transmission, including in the Bay Area, is at an all-time high.
All of us, including those who have been vaccinated, must continue to adhere to public health orders, wearing masks, physically distancing, washing hands, and avoiding unnecessary travel and gatherings. Despite the fatigue we all feel, we must stay vigilant in taking all appropriate steps to slow the pandemic and avoid mistaking a vaccine for a cure.
Following FDA approval, the California Department of Public Health (CDPH) is expected to authorize use of the Pfizer vaccine in California. With the CDPH’s authorization, and aligned with public health guidance, UCSF will offer vaccinations to those on the front lines of the pandemic as early as next week.
As vaccine manufacturing capacity ramps up, a phased plan for distributing the vaccine is required. Initially, UCSF will offer the vaccine to those who have the highest risk of exposure to...